Cancer cell proliferation in CRPC is considered to result from androgen receptor (AR) overexpression, AR mutations responsible for ligand-independent constitutive AR activity or promiscuous ligand activation of AR, intracrine steroid biosynthesis, acceleration of AR-independent mitogenic signals, etc.10–12. This evidence concerns the gene AR and cancer.